132 related articles for article (PubMed ID: 35366784)
1. A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding Onwards.
Mukherjee S; Ray SK
Infect Disord Drug Targets; 2022; 22(6):e010422202932. PubMed ID: 35366784
[TBL] [Abstract][Full Text] [Related]
2. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference.
Mukherjee S; Ray SK
Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456
[TBL] [Abstract][Full Text] [Related]
3. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
5. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
[TBL] [Abstract][Full Text] [Related]
6. Novel SARS-CoV-2 variants: the pandemics within the pandemic.
Boehm E; Kronig I; Neher RA; Eckerle I; Vetter P; Kaiser L;
Clin Microbiol Infect; 2021 Aug; 27(8):1109-1117. PubMed ID: 34015535
[TBL] [Abstract][Full Text] [Related]
7. The novel zoonotic COVID-19 pandemic: An expected global health concern.
Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
[TBL] [Abstract][Full Text] [Related]
8. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
[TBL] [Abstract][Full Text] [Related]
9. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
Malik JA; Ahmed S; Mir A; Shinde M; Bender O; Alshammari F; Ansari M; Anwar S
J Infect Public Health; 2022 Feb; 15(2):228-240. PubMed ID: 35042059
[TBL] [Abstract][Full Text] [Related]
10. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
Zawilska JB; Lagodzinski A; Berezinska M
J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
[TBL] [Abstract][Full Text] [Related]
11. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast.
Inchingolo AD; Malcangi G; Ceci S; Patano A; Corriero A; Vimercati L; Azzollini D; Marinelli G; Coloccia G; Piras F; Barile G; Settanni V; Mancini A; De Leonardis N; Garofoli G; Palmieri G; Isacco CG; Rapone B; Scardapane A; Curatoli L; Quaranta N; Ribezzi M; Massaro M; Jones M; Bordea IR; Tartaglia GM; Scarano A; Lorusso F; Macchia L; Larocca AMV; Aityan SK; Tafuri S; Stefanizzi P; Migliore G; Brienza N; Dipalma G; Favia G; Inchingolo F
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955621
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
[TBL] [Abstract][Full Text] [Related]
15. The Pandemic of Coronavirus Disease 2019 (COVID-19).
Rashid NN
Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
[TBL] [Abstract][Full Text] [Related]
16. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.
Noor R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150
[TBL] [Abstract][Full Text] [Related]
17. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic.
El-Shabasy RM; Nayel MA; Taher MM; Abdelmonem R; Shoueir KR; Kenawy ER
Int J Biol Macromol; 2022 Apr; 204():161-168. PubMed ID: 35074332
[TBL] [Abstract][Full Text] [Related]
18. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
[TBL] [Abstract][Full Text] [Related]
19. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
20. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
